Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

St. Luke’s, Greater Delaware Valley Chapter of MS Society partner to improve MS care

St. Luke’s Neurology Associates and the Greater Delaware Valley Chapter of the National Multiple Sclerosis Society agreed to a “Partners in MS Care” partnership.

28 May 2015

Novartis launches ‘24 Life Hacks in 24 hours’ showing commitment to help people with MS access guidance and advice

World MS Day was created by the Multiple Sclerosis International Foundation (MSIF) in 2009 to raise global awareness of MS...

28 May 2015

UC San Diego Health System designated as Center of Excellence for Huntington's disease

The Huntington's Disease Clinical Research Center at UC San Diego Health System has been designated a Center of Excellence by the Huntington's Disease Society of America. UC San Diego was one of only 29 centers nationwide to receive this prestigious designation, which recognizes centers for their elite multidisciplinary approach to Huntington's disease care and research.

27 May 2015

New Health Union study finds severe impact of rheumatoid arthritis on patients' quality of life

In a new national survey of rheumatoid arthritis (RA) patients, Health Union found a severe impact on quality of life, employment, and ability to afford treatment. The autoimmune condition attacks the body, resulting in joint inflammation, pain, stiffness, and swelling, but may also harm other organs. About 1.3 million Americans or about one percent of the global population have RA.

27 May 2015

Researchers find that blocking MCAM molecule could slow progression of multiple sclerosis

A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM, and they have shown that blocking this molecule could delay the onset of the disease and significantly slow its progression.

21 May 2015

New research points to potential therapeutic target for treating multiple sclerosis

New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty "brake" within immune cells, a brake that should be controlling the inflammation. This points to a potential target for developing new therapies to treat multiple sclerosis and could have important implications for other autoimmune diseases, such as the colon disease colitis and the chronic skin condition atopic dermatitis.

20 May 2015

fMRI reflects interactions between brain regions

Tübingen neuroscientists have made an important advance in studying the human brain with functional magnetic resonance imaging (fMRI).

18 May 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19.

17 May 2015

Regulatory T cells can cure inflammatory diseases, shows research

Scientists at The University of Manchester have made an important discovery about an immune cell which is already being used in immunotherapy to treat diseases such as type I diabetes.

14 May 2015

TSRI researchers find interferon beta protein as prime suspect in persistent viral infections

Interferon proteins are normally considered virus-fighters, but scientists at The Scripps Research Institute have found evidence that one of them, interferon beta (IFNβ), has an immune-suppressing effect that can help some viruses establish persistent infections.

14 May 2015

Major breakthrough in understanding development of type 1 diabetes

Joslin researchers have uncovered the action of a gene that regulates the education of T cells, providing insight into how and why the immune system begins mistaking the body's own tissues for targets. The gene, Clec16a, is one of a suite of genes associated with multiple autoimmune disorders, suggesting it is fundamental to the development of autoimmunity.

13 May 2015

UAB opens third multidisciplinary clinic for transverse myelitis

Mike Jezdimir knows firsthand how hard it is to get appropriate medical treatment for his condition, a disease of the spinal cord called transverse myelitis. He has had it for 48 years, since he was 17. TM is fairly uncommon, and many physicians rarely encounter it. Treatment options are limited.

13 May 2015

Perrigo announces acquisition of Patheon's Mexican operations for $34 million

Perrigo Company plc announced today that it has acquired the Mexican operations of Durham, North Carolina-based Patheon for $34 million in cash.

12 May 2015

Discovery paves way for developing treatments for people addicted to cocaine, amphetamines

In a major advance in the field of neuropsychiatry, researchers in the Vollum Institute at Oregon Health & Science University have illuminated how cocaine and amphetamines disrupt the normal functioning of the dopamine transporter in the brain.

12 May 2015

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.

7 May 2015

Cardiff scientists develop novel anti-cancer stem cell compound

Cardiff University scientists have developed a novel anti-cancer stem cell agent capable of targeting aggressive tumour forming cells common to breast, pancreas, colon and prostate cancers.

7 May 2015

UT Southwestern's new operating suite integrates surgical and endovascular techniques in one space

UT Southwestern Medical Center has established a Hybrid Cerebrovascular Operating Suite at Zale Lipshy University Hospital that will combine surgical innovations with advanced imaging capabilities for surgical cases related to stroke and brain aneurysms.

7 May 2015

New study finds that challenging work tasks may have significant effect on brain health

Professionals whose jobs require more speaking, developing strategies, conflict resolution and managerial tasks may experience better protection against memory and thinking decline in old age than their co-workers, according to a new study published in the April 29, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

30 Apr 2015

Cytokine GM-CSF likely plays important role in MS

Multiple sclerosis (MS) is caused by immune cells that activate a cascade of chemicals in the brain, attacking and degrading the insulation that keeps neuronal signals moving. These chemicals, called cytokines, drive the inflammation in the brain, attracting more immune cells, and causing the debilitating disease marked by loss of neurological function.

30 Apr 2015

Parents share arduous, circuitous journey to get referrals for childhood epilepsy surgery

Having a child diagnosed with epilepsy can be a frightening and confusing time. Now, parents share their arduous and "circuitous" journey to get referrals for pediatric epilepsy surgery once their child's disease stops responding to anti-seizure medications. The UCLA study sheds light on the difficulties parents face obtaining specialty and sub-specialty care for their children during an already stressful time.

30 Apr 2015

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

St. Luke’s, Greater Delaware Valley Chapter of MS Society partner to improve MS care

Novartis launches ‘24 Life Hacks in 24 hours’ showing commitment to help people with MS access guidance and advice

UC San Diego Health System designated as Center of Excellence for Huntington's disease

New Health Union study finds severe impact of rheumatoid arthritis on patients' quality of life

Researchers find that blocking MCAM molecule could slow progression of multiple sclerosis

New research points to potential therapeutic target for treating multiple sclerosis

fMRI reflects interactions between brain regions

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Regulatory T cells can cure inflammatory diseases, shows research

TSRI researchers find interferon beta protein as prime suspect in persistent viral infections

Major breakthrough in understanding development of type 1 diabetes

UAB opens third multidisciplinary clinic for transverse myelitis

Perrigo announces acquisition of Patheon's Mexican operations for $34 million

Discovery paves way for developing treatments for people addicted to cocaine, amphetamines

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

Cardiff scientists develop novel anti-cancer stem cell compound

UT Southwestern's new operating suite integrates surgical and endovascular techniques in one space

New study finds that challenging work tasks may have significant effect on brain health

Cytokine GM-CSF likely plays important role in MS

Parents share arduous, circuitous journey to get referrals for childhood epilepsy surgery

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Newsletters you may be interested in